A combination of hemorrhagic and ulcerative necrotic forms of polymorphic dermal angiitis in a female patient with B-cell lymphoma receiving biological therapy

Elena A. Muravyova; O. Yu Olisova; E. A Nikitin

doi:10.17816/dv36961

Russian Journal of Skin and Venereal Diseases ›› 2015, Vol. 18 ›› Issue (3) : 23 -26. DOI: 10.17816/dv36961

Articles

research-article

A combination of hemorrhagic and ulcerative necrotic forms of polymorphic dermal angiitis in a female patient with B-cell lymphoma receiving biological therapy

Author information +

History +

PDF

Abstract

Angiitis (skin vasculitis) is a dermatosis the key component of which is nonspecific inflammation of the dermal and hypodermal blood vessels of different diameters. Infection and drug hypersensitivity are the most significant factors triggering the disease development. This paper presents a case with polymorphic dermal angiitis - a combination of the hemorrhagic and ulcerative necrotic form, unfolding under conditions of rituksimab therapy in a 53-year-old female patient with chronic lymphoid leukemia (CLL). Painful eruptions on the skin of both legs emerged after the 5 th intravenous injection of rituksimab. The skin process progressed during several days, the pain in the foci augmented. Rituksimab is a drug based on synthetic (gene engineering) chimerical human/mouse monoclonal antibodies specific to CD20 antigen, detected on the surface of normal and malignant B lymphocytes. The drug is used in therapy for B-cell non-Hodgkin’s lymphomas in adult patients.

Keywords

polymorphic dermal angiitis / rituksimab / chronic lymphoid leukemia / systemic glucocorticosteroids

Cite this article

Download citation ▾

Elena A. Muravyova, O. Yu Olisova, E. A Nikitin. A combination of hemorrhagic and ulcerative necrotic forms of polymorphic dermal angiitis in a female patient with B-cell lymphoma receiving biological therapy. Russian Journal of Skin and Venereal Diseases, 2015, 18(3): 23-26 DOI:10.17816/dv36961

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Иванов О.Л. Ангииты кожи. Руководство для врачей. В кн.: Скрипкин Ю.К., Бутов Ю.С., ред. Клиническая дерматовенерология. М.: ГЭОТАР-Медиа; 2009. т. 2: 576-89.

[2]	Бутов Ю.С., Волкова Е.Н., Марченко Л.Ф. Мембранопатии при ангиитах кожи. Российский журнал кожных и венерических болезней. 1998; 1: 23-5.

[3]	Насонов Е.Л., Баранов А.А., Шилкина Н.П. Васкулиты и васкулопатии. Ярославль: Верхняя Волга; 1999: 479-515.

[4]	Дворянкова Е.В., Тамразова Е.В., Корсунская И.М. Эрозивно-язвенные поражения кожи. Васкулиты. Клиническая дерматология и венерология. 2007; 3: 64-9.

[5]	Иванов О.Л. Современная классификация и клиническое течение ангиитов (васкулитов) кожи. Русский медицинский журнал. 1997; 11: 53-7.

[6]	Johnson P.W., Glennie M.J. Rituximab: mechanisms and applications. Br. J. Cancer. 2001; 85(11): 1619-23.

[7]	Anderson K.C., Bates M.P, Slaughenhoupt B.L., Pinkus G.S., Schlossman S.F., Nadler L.M. Expression of human B-cell associated antigens in leukaemias and lymphomas: a model of human B-cell differentiation. Blood. 1984; 63(6): 1424-33.

[8]	McLaughlin P., Grillo-Lopez A.J., Link B.K., Levy R., Czuczman M.S., Williams M.E., et al. Rituximab chimeric anti-CD 20 monoclonal antibody therapy for relapsed indolent lymphoma. J. Clin. Oncol. 1998; 16(8): 2825-33.